| scholarly article | Q13442814 |
| P2093 | author name string | John M Leong | |
| Dakshina M Jandhyala | |||
| Beth A McCormick | |||
| Erik J Boll | |||
| Vijay Vanguri | |||
| Yushuan Lai | |||
| P2860 | cites work | Enteroaggregative Escherichia coli as a potential cause of diarrheal disease in adults infected with human immunodeficiency virus | Q45755093 |
| Cytotoxic effect of Shiga toxin-1 on human proximal tubule cells | Q47742188 | ||
| SepA, the major extracellular protein of Shigella flexneri: autonomous secretion and involvement in tissue invasion | Q48072701 | ||
| Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance. | Q50557922 | ||
| Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study. | Q52034506 | ||
| Prognostic factors in hospitalized children with persistent diarrhea: implications for diet therapy. | Q52300371 | ||
| Azithromycin decolonization of STEC--a new risk emerges. | Q54335202 | ||
| Therapy: Azithromycin and decolonization after HUS. | Q54337402 | ||
| Aggregative adherence fimbriae contribute to the inflammatory response of epithelial cells infected with enteroaggregative Escherichia coli. | Q54638065 | ||
| Enteroaggregative Escherichia coli associated with persistent diarrhea in a cohort of rural children in India. | Q54729329 | ||
| Characterization of enteroadherent-aggregative Escherichia coli, a putative agent of diarrheal disease. | Q54746605 | ||
| Hemolytic Uremic Syndrome | Q56336649 | ||
| ESCHERICHIA COLI CYTOTOXIN, HAEMOLYTIC-URAEMIC SYNDROME, AND HAEMORRHAGIC COLITIS | Q57676149 | ||
| Enteroaggregative Escherichia coli | Q58876375 | ||
| Should all adult patients with diarrhoea-associated HUS receive plasma exchange? | Q60265730 | ||
| Drug resistance and adherence to human intestines of enteroaggregative Escherichia coli | Q68080087 | ||
| Cytotoxic effect of Shiga toxin-1 on human glomerular epithelial cells | Q73873452 | ||
| Enteroaggregative Escherichia coli as a cause of traveler's diarrhea: clinical response to ciprofloxacin | Q78221598 | ||
| Direct faecal PCR for diagnosis of Shiga-toxin-producing Escherichia coli | Q83333355 | ||
| Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology | Q21091008 | ||
| Enteroaggregative Escherichia coli: An Emerging Enteric Food Borne Pathogen | Q21328680 | ||
| Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections | Q24550740 | ||
| Azithromycin and the risk of cardiovascular death | Q24604355 | ||
| The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections | Q24623245 | ||
| Toxin gene expression by shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response | Q24647531 | ||
| A case of hemolytic uremic syndrome caused by Escherichia coli O104:H4 | Q24654024 | ||
| Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons | Q24658046 | ||
| Solution structure of the novel dispersin protein of enteroaggregative Escherichia coli | Q27648971 | ||
| Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression | Q28211358 | ||
| Eculizumab in severe Shiga-toxin-associated HUS | Q28238525 | ||
| Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany | Q28244221 | ||
| Pathogenic Escherichia coli | Q29616738 | ||
| Pet, an autotransporter enterotoxin from enteroaggregative Escherichia coli. | Q30176142 | ||
| Enteroaggregative Escherichia coli expresses a novel flagellin that causes IL-8 release from intestinal epithelial cells. | Q30305779 | ||
| Virulence of the Shiga toxin type 2-expressing Escherichia coli O104:H4 German outbreak isolate in two animal models | Q30416578 | ||
| The fimbriae of enteroaggregative Escherichia coli induce epithelial inflammation in vitro and in a human intestinal xenograft model | Q30417449 | ||
| Characterization of the AggR regulon in enteroaggregative Escherichia coli | Q30418503 | ||
| Genomic characterization of enteroaggregative Escherichia coli from children in Mali | Q30428800 | ||
| Serine protease autotransporters from Shigella flexneri and pathogenic Escherichia coli target a broad range of leukocyte glycoproteins | Q30431075 | ||
| Enteroaggregative Escherichia coli | Q30439620 | ||
| CXCL1/KC and CXCL2/MIP-2 are critical effectors and potential targets for therapy of Escherichia coli O157:H7-associated renal inflammation | Q30442733 | ||
| Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection | Q33330974 | ||
| Chronic diarrhea, hemorrhagic colitis, and hemolytic-uremic syndrome associated with HEp-2 adherent Escherichia coli in adults infected with human immunodeficiency virus in Bangui, Central African Republic | Q33343452 | ||
| Risk factors for the central nervous system manifestations of gastroenteritis-associated hemolytic-uremic syndrome | Q33354389 | ||
| Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin I. | Q33364452 | ||
| Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome | Q33365488 | ||
| Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion | Q33366604 | ||
| The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli | Q33373301 | ||
| Hemorrhagic Colitis Associated with a RareEscherichia coliSerotype | Q34256166 | ||
| Correlation between in vivo biofilm formation and virulence gene expression in Escherichia coli O104:H4. | Q34358725 | ||
| Escherichia coli O157:H7. | Q34391524 | ||
| An IncI1 plasmid contributes to the adherence of the atypical enteroaggregative Escherichia coli strain C1096 to cultured cells and abiotic surfaces | Q34492804 | ||
| A novel dispersin protein in enteroaggregative Escherichia coli | Q34815535 | ||
| Aggregative adherence fimbria II, a second fimbrial antigen mediating aggregative adherence in enteroaggregative Escherichia coli. | Q35556396 | ||
| Presence of enterohemorrhagic Escherichia coli ST678/O104:H4 in France prior to 2011 | Q35599259 | ||
| Enteroaggregative Escherichia coli pathogenesis | Q36028070 | ||
| Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclature | Q36172302 | ||
| Enteroaggregative Escherichia coli heat-stable enterotoxin 1 represents another subfamily of E. coli heat-stable toxin | Q36219150 | ||
| New adhesin of enteroaggregative Escherichia coli related to the Afa/Dr/AAF family | Q36747051 | ||
| Distinctive patterns of adherence of enteropathogenic Escherichia coli to HeLa cells | Q37077312 | ||
| Verocytotoxin-producing Escherichia coli (VTEC). | Q37467549 | ||
| Acute bloody diarrhea: a medical emergency for patients of all ages. | Q37490296 | ||
| Autotransporters and virulence of enteroaggregative E. coli. | Q37884346 | ||
| Pathogenesis of Shiga-toxin producing escherichia coli. | Q37931746 | ||
| The induction of apoptosis by Shiga toxins and ricin | Q37963278 | ||
| Enteroaggregative Escherichia coli pathotype: a genetically heterogeneous emerging foodborne enteropathogen | Q38024836 | ||
| Potential role of adherence traits of Escherichia coli in persistent diarrhea in an urban Brazilian slum | Q39243122 | ||
| Cytoskeletal effects induced by pet, the serine protease enterotoxin of enteroaggregative Escherichia coli | Q39610447 | ||
| Enteroaggregative Escherichia coli Disrupts Epithelial Cell Tight Junctions | Q39658552 | ||
| Adhesion of enteroaggregative Escherichia coli to pediatric intestinal mucosa in vitro | Q39826618 | ||
| AggR, a transcriptional activator of aggregative adherence fimbria I expression in enteroaggregative Escherichia coli | Q39896258 | ||
| Laboratory investigation of enteroaggregative Escherichia coli O untypeable:H10 associated with a massive outbreak of gastrointestinal illness | Q40014564 | ||
| Studies with enteroaggregative Escherichia coli in the gnotobiotic piglet gastroenteritis model | Q40152628 | ||
| Diarrheagenic Escherichia coli infection in Baltimore, Maryland, and New Haven, Connecticut. | Q40474671 | ||
| Commensal bacteria influence Escherichia coli O157:H7 persistence and Shiga toxin production in the mouse intestine | Q42203695 | ||
| Similarity of Shiga toxin-producing Escherichia coli O104:H4 strains from Italy and Germany | Q42572253 | ||
| Proteomic and microarray characterization of the AggR regulon identifies a pheU pathogenicity island in enteroaggregative Escherichia coli | Q42596037 | ||
| The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis | Q42856082 | ||
| A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea | Q43894968 | ||
| A tyrosine-phosphorylated 12-amino-acid sequence of enteropathogenic Escherichia coli Tir binds the host adaptor protein Nck and is required for Nck localization to actin pedestals | Q43936783 | ||
| Enteroaggregative Escherichia coli diarrhea in travelers: response to rifaximin therapy | Q44797478 | ||
| Enteroaggregative Escherichia coli associated with a foodborne outbreak of gastroenteritis | Q44883649 | ||
| Clinical spectrum of Shiga toxin-producing Escherichia coli (STEC) in adults and children | Q44939982 | ||
| Analysis of collection of hemolytic uremic syndrome-associated enterohemorrhagic Escherichia coli | Q33380625 | ||
| Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS). | Q33380757 | ||
| Shiga toxin-associated hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: distinct mechanisms of pathogenesis | Q33383009 | ||
| Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006. | Q33386636 | ||
| Recommendations for diagnosis of shiga toxin--producing Escherichia coli infections by clinical laboratories | Q33386665 | ||
| Treatment of typical (enteropathic) hemolytic uremic syndrome | Q33392003 | ||
| Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease | Q33394010 | ||
| Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany | Q33395886 | ||
| Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study | Q33395933 | ||
| Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome | Q33396329 | ||
| Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations | Q33396501 | ||
| Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: an observational study | Q33396885 | ||
| Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial | Q33397004 | ||
| Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota | Q33397014 | ||
| German outbreak of Escherichia coli O104:H4 associated with sprouts | Q33397821 | ||
| Management of hemolytic uremic syndrome | Q33399370 | ||
| Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4. | Q33400244 | ||
| Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study | Q33402456 | ||
| Renal and neurological involvement in typical Shiga toxin-associated HUS. | Q33403361 | ||
| Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry | Q33404151 | ||
| Ciprofloxacin reduces the risk of hemolytic uremic syndrome in patients with Escherichia coli O104:H4-associated diarrhea. | Q33405117 | ||
| A severe outbreak of Escherichia coli O157:H7--associated hemorrhagic colitis in a nursing home | Q33450098 | ||
| A continuing assessment of risk factors for the development of Escherichia coli O157:H7-associated hemolytic uremic syndrome. | Q33491139 | ||
| Endothelial heterogeneity in Shiga toxin receptors and responses. | Q33493734 | ||
| Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections | Q33499640 | ||
| Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents. | Q33505061 | ||
| The immunogenic SigA enterotoxin of Shigella flexneri 2a binds to HEp-2 cells and induces fodrin redistribution in intoxicated epithelial cells | Q33518453 | ||
| Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo | Q33617990 | ||
| Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. | Q33889513 | ||
| Shiga toxins induce, superinduce, and stabilize a variety of C-X-C chemokine mRNAs in intestinal epithelial cells, resulting in increased chemokine expression | Q34009265 | ||
| Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. | Q34049372 | ||
| Different classes of antibiotics differentially influence shiga toxin production | Q34108726 | ||
| Patterns of adherence of diarrheagenic Escherichia coli to HEp-2 cells | Q34173805 | ||
| Pic, an autotransporter protein secreted by different pathogens in the Enterobacteriaceae family, is a potent mucus secretagogue | Q34177330 | ||
| P433 | issue | 3 | |
| P921 | main subject | Escherichia coli | Q25419 |
| emerging pathogen | Q108429945 | ||
| P304 | page(s) | 631-649 | |
| P577 | publication date | 2013-07-24 | |
| P1433 | published in | Infectious Disease Clinics of North America | Q15754797 |
| P1476 | title | Shiga toxin-producing Escherichia coli O104:H4: an emerging pathogen with enhanced virulence | |
| P478 | volume | 27 |
| Q53729611 | Characterization of four Escherichia coli clonal groups. |
| Q59809358 | High frequency of hybrid Escherichia coli strains with combined Intestinal Pathogenic Escherichia coli (IPEC) and Extraintestinal Pathogenic Escherichia coli (ExPEC) virulence factors isolated from human faecal samples |
| Q89994040 | Interactions of Shiga toxin-producing Escherichia coli with leafy green vegetables |
| Q33419554 | Safe and effective use of eculizumab in the treatment of severe Shiga toxin Escherichia coli-associated hemolytic uremic syndrome |
| Q30657658 | Shiga toxin type-2 (Stx2) induces glutamate release via phosphoinositide 3-kinase (PI3K) pathway in murine neurons |
| Q35154085 | Two novel EHEC/EAEC hybrid strains isolated from human infections. |
Search more.